PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

AI could predict breast cancer risk via ‘zombie cells’

2024-09-25
(Press-News.org) Women worldwide could see better treatment with new AI technology which enables better detection of damaged cells and more precisely predict the risk of getting breast cancer, shows new research from the University of Copenhagen. Breast cancer is one of the most common types of cancer. In 2022, the disease caused 670,000 deaths worldwide. Now, a new study from the University of Copenhagen shows that AI can help women with improved treatment by scanning for irregular-looking cells to give better risk assessment.

The study, published in The Lancet Digital Health, found that the AI technology was far better at predicting risk of cancer than current clinical benchmarks for breast cancer risk assessment.

The researchers used deep learning AI technology developed at the University of Copenhagen to analyze mammary tissue biopsies from donors to look for signs of damaged cells, an indicator of cancer risk.

“The algorithm is a great leap forward in our ability to identify these cells. Millions of biopsies are taken every year, and this technology can help us better identify risks and give women better treatment,” says Associate Professor Morten Scheibye-Knudsen from the Department of Cellular and Molecular Medicine and senior author of the study.

Predicts cases of five times the risk of breast cancer A core aspect of assessing cancer risk is looking for dying cells, caused by so-called cellular senescence. Senescent cells are still metabolically active but have stopped dividing. Previous research has shown that this senescent state can help suppress cancer development. However, senescent cells can also cause inflammation that can lead to tumor development.

By using deep learning AI to search for senescent cells in tissue biopsies, the researchers were able to predict the risk of breast cancer better than the Gail model, the current gold standard for assessing breast cancer risk.

“We also found that if we combine two of our own models or one of our models with the Gail score, we get results that are far better at predicting risk of getting cancer. One model combination gave us an odds ratio of 4.70 and that is huge. It is significant if we can look at cells from an otherwise healthy biopsy sample and predict that the donor has almost five times the risk of developing cancer several years later,” says Indra Heckenbach, first author of the study.

Algorithm trained on ‘zombie cells’ can give better treatment The researchers trained the AI technology on cells developed in cell culture that were intentionally damaged to make them senescent. The researchers then used the AI on the donor biopsies to detect senescent cells.

“We sometimes refer to them as zombie cells because they have lost some of their function, but they are not quite dead. They are associated with cancer development, so we developed and trained the algorithm to predict cell senescence. Specifically, our algorithm looks at how the cell nuclei are shaped, because the nuclei become more irregular when the cells are senescent,” explains Indra Heckenbach.

It will still be several years until the technology is available to use at the clinic, but then it can be applied worldwide, as it only requires standard tissue sample images to do the analysis. Then, women around the globe can potentially use this new insight to get better treatment, Morten Scheibye-Knudsen adds:

“We will be able use this information to stratify patients by risk and improve treatment and screening protocols. Doctors can keep a closer eye on high-risk individuals, they can undergo more frequent mammograms and biopsies, and we can potentially catch cancer earlier. At the same time, we can reduce the burden for low-risk individuals, e.g. by taking biopsies less frequently.”

Read the study “Deep learning assessment of senescence-associated nuclear morphologies in mammary tissue from healthy female donors to predict future risk of breast cancer: a retrospective cohort study”.

 

END


ELSE PRESS RELEASES FROM THIS DATE:

Breakthrough research identifies new targets for wound healing

2024-09-25
(Thursday, 26 September 2024) Novel research, presented today at the European Academy of Dermatology and Venereology (EADV) Congress 2024, has identified key molecular targets that could significantly enhance the healing of both acute and chronic wounds.1  These findings represent a crucial advancement in wound care, paving the way for more effective treatment options and improved patient outcomes. Globally, acute and chronic wounds affect nearly one billion people.2 In particular, chronic wounds pose a substantial economic burden on healthcare systems and severely impact ...

Are branch faults the “on-ramps” that lead to great continental transform earthquakes?

2024-09-25
The five largest continental transform earthquakes since 2000 all originated on a branch of the main fault—and two researchers predict that the next great earthquake of this type will also get its start on a branch or splay fault. Last year’s magnitude 7.8 Pazarcık earthquake in Türkiye was one of these large and damaging earthquakes, where two continental tectonic plates slide past each other horizontally. That earthquake began on a branch fault, as did the 2001 magnitude 7.8 Kokoxili earthquake in northern Tibet, the 2002 magnitude 7.9 Denali earthquake in Alaska, the 2008 magnitude 7.9 Wenchuan earthquake in China, and the 2016 ...

Tumour-specific antibodies able to detect melanoma in its earliest stages, new study shows

2024-09-25
(Thursday, 26 September 2024, Amsterdam, Netherlands) Innovative research has unveiled promising advancements in melanoma detection, which could significantly enhance diagnosis and prognosis by identifying the disease at its earliest, most treatable stages.1 This new method, presented today at the European Academy of Dermatology and Venereology (EADV) Congress 2024, uses tumour-specific profiling to detect antibodies unique to stage I and II melanoma patients. Melanoma, a skin cancer with a high mutation rate,2 ...

When a child hurts, validating their pain may be the best first aid

2024-09-25
Whether it’s a sore arm or a fear of injections, how a child is treated when they present with pain could significantly affect how they respond to and manage pain later in life.   In a new study from the University of South Australia, researchers say that parents and doctors should be mindful of how they talk to and treat children experiencing pain – no matter how big or small the injury – knowing that these foundational experiences can be carried forward into adulthood.   Drawing from diverse research across developmental psychology, child mental health, and pain sciences, researchers say that it may be important to validate children’s pain by ...

Single-dose gene therapy is potentially life-changing for adults with hemophilia B

2024-09-25
PHILADELPHIA – Adults with hemophilia B saw their number of bleeding episodes drop by an average of 71 percent after a single infusion of gene therapy, according to the results of an international Phase III clinical trial published today in the New England Journal of Medicine by researchers from the University of Pennsylvania Perelman School of Medicine and a multicenter group of investigators. Hemophilia is a genetic disorder that limits the blood’s ability to clot and affects around 30,000 people in the United States, ...

NEJM: Results from targeted therapy for ulcerative colitis study

2024-09-25
An international placebo-controlled study led by Cedars-Sinai suggests that a targeted drug therapy that was developed by researchers at Cedars-Sinai is safe and effective at helping people with moderate to severe ulcerative colitis reach clinical remission. Results from the multicenter Phase II study, ARTEMIS-UC, were published in The New England Journal of Medicine. Ulcerative colitis is a type of inflammatory bowel disease (IBD) that damages the digestive tract, causing stomach cramping, diarrhea, weight loss and rectal bleeding. ...

Study finds certain MS therapies may not slow disability progression

2024-09-25
EMBARGOED FOR RELEASE UNTIL 4 P.M. ET, WEDNESDAY, SEPTEMBER 25, 2024 MINNEAPOLIS – In people with primary progressive multiple sclerosis (MS), a new study has found no difference in the amount of time before disability worsened between people taking certain medications and those not receiving treatment. The study is published in the September 25, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology. With MS, the body’s immune system attacks myelin, the fatty, white substance that insulates and protects the nerves. People with ...

Are gender and sexual identity linked to brain health?

2024-09-25
EMBARGOED FOR RELEASE UNTIL 4 P.M. ET, WEDNESDAY, SEPTEMBER 25, 2024 MINNEAPOLIS – LGBTQ+ people may be more likely to have negative brain health outcomes, including a higher risk of dementia and late-life depression, than people who are cisgender and straight, according to a study published in the September 25, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology. These results do not prove that sexual or gender diversity causes neurological diseases, they only show an association. LGBTQ+ refers to people who are lesbian, gay, bisexual, transgender, ...

The Academy of Science of St. Louis names Katherine Polokonis as executive director

2024-09-25
ST. LOUIS, MO, September 25, 2024 – After an extensive search, The Academy of Science of St. Louis has named Katherine Polokonis as the next Executive Director. “After a rigorous search, we are looking forward to Kate’s transformational leadership of The Academy of Science,” said Toni Kutchan, PhD, president of the Board of Trustees of the Academy and member emerita, Donald Danforth Plant Science Center. “Kate's comprehensive experience in STEM education and passion for social equity make her ...

How synchronization supports social interactions

How synchronization supports social interactions
2024-09-25
Turn-taking dynamics of social interactions are important for speech and gesture synchronization, enabling conversations to proceed efficiently, according to a study published September 25, 2024, in the open-access journal PLOS ONE by Tifenn Fauviaux from the University of Montpellier, France, and colleagues. Conversations encompass continuous exchanges of verbal and nonverbal information. Previous research has demonstrated that gestures and speech synchronize at the individual level. But few studies have investigated how this phenomenon ...

LAST 30 PRESS RELEASES:

Prevalence, determinants, and time trends of cardiovascular health in the WHO African region

New study finds that, after a heart attack, women have worse prognosis when treated with beta-blockers

CNIC-led REBOOT clinical trial challenges 40-year-old standard of care for heart attack patients

Systolic blood pressure and microaxial flow pump–associated survival in infarct-related cardiogenic shock

Beta blockers, the standard treatment after a heart attack, may offer no benefit for heart attack patients and women can have worse outcomes

High Mountain Asia’s shrinking glaciers linked to monsoon changes

All DRII-ed up: How do plants recover after drought?

Research on stigma says to just ‘shake it off’

Scientists track lightning “pollution” in real time using NASA satellite

Millions of women rely on contraceptives, but new Rice study shows they may do more than just prevent pregnancy

Hot days make for icy weather, Philippine study finds

Roxana Mehran, MD, receives the most prestigious award given by the European Society of Cardiology

World's first clinical trial showing lubiprostone aids kidney function

Capturing language change through the genes

Public trust in elections increases with clear facts

Thawing permafrost raised carbon dioxide levels after the last ice age

New DNA test reveals plants’ hidden climate role

Retinitis pigmentosa mouse models reflect pathobiology of human RP59

Cell’s ‘antenna’ could be key to curing diseases

Tiny ocean partnership between algae and bacteria reveals secrets of evolution

Scientists uncover cellular “toolkit” to reprogram immune cells for cancer therapy

Blocking protein control pathway slows rhabdomyosarcoma growth in mice

2026 Hertz Fellowship Application Now Open

The gut immune system is altered in mouse model of Alzheimer’s, providing a new target for therapeutics

ADHD drugs are being prescribed too quickly to preschoolers

UCLA scientists develop off-the-shelf immunotherapy for metastatic kidney cancer

Extreme heat linked to spike in domestic violence calls in New Orleans, study finds

Mount Sinai-Duke University study identifies DNA variants that increase testosterone production in PCOS patients

Physiology-guided complete revascularization in older patients with myocardial infarction

Metals and sulfate in air pollution mixture may contribute most to asthma hospitalizations

[Press-News.org] AI could predict breast cancer risk via ‘zombie cells’